Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1449 of 6351
-
Experimental cell infusion aims to tame childhood autoimmune diseases
Disease control Not yet recruitingThis exploratory, single-arm, open-label study will evaluate the safety and preliminary efficacy of YTS109 cell therapy in pediatric patients with relapsed/refractory autoimmune diseases, including systemic lupus erythematosus, diffuse systemic sclerosis, idiopathic inflammatory …
Phase 1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New COPD inhaler put to the test in Year-Long safety study
Disease control Not yet recruitingThis clinical trial evaluates the long-term safety and efficacy of 0.75 mg HSK39004 Dry Powder Inhaler administered twice daily for 52 weeks in subjects aged 40 to 80 years with moderate-to-severe stable chronic obstructive pulmonary disease (COPD), including both newly enrolled …
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Brain zaps to sharpen bipolar minds: new trial tests quick fix for foggy thinking
Symptom relief Not yet recruitingBipolar disorder is a highly disabling psychiatric illness, and cognitive impairment is common in patients with bipolar depression as well as during remission, contributing substantially to functional disability and poorer prognosis. Currently, effective interventions specificall…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Could coiling an artery in the head stop migraines?
Disease control Not yet recruitingThis single-site, open-label pilot study evaluates the safety, feasibility, and potential durability of the TEMMA procedure (Targeted Embolization for Migraine Management), an endovascular treatment strategy targeting meningeal arterial contributors to migraine. Adults aged 18-60…
Sponsor: Cortex Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Cockroach extract may shield cancer patients from radiation burns
Prevention Recruiting nowTo evaluate the efficacy and safety of topical Periplaneta americana-derived Meilian Fuxin Solution for the prevention of radiation dermatitis in patients undergoing radiotherapy.
Phase 2/3 • Sponsor: West China Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New nanoparticle drug aims to fight tough lung cancer
Disease control Recruiting nowThe purpose of the Phase 1 research is to test the safety, tolerability, maximum tolerated dose, and pharmacokinetics (PK- the study of how a medicine moves through subject body. It looks at how the drug is absorbed, travels in your blood, reaches different parts of subject body,…
Phase 1/2 • Sponsor: SN BioScience • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Say 'Bend Arm' to recover: Voice-Activated robot may boost stroke rehab
Symptom relief Not yet recruitingThis study aims to investigate whether combining "motor imagery" (the mental visualization of movement) with robotic exoskeleton therapy can improve upper limb recovery in stroke patients. Conventional robotic therapy often involves passive movement driven by the machine. In this…
Sponsor: Taipei Hospital, Ministry of Health and Welfare • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New asthma drug AK139 enters phase 2 trial – hope for better lung function?
Disease control Not yet recruitingThis is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe asthma.
Phase 2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a simple heart pump save lives after a heart attack complication?
Disease control Not yet recruitingVentricular septal defect (MI-VSD) is a serious mechanical complication of acute myocardial infarction, with an extremely high mortality. Intra-aortic balloon pump (IABP) is still the most easily available mechanical assistive device for clinical management, and it has become a b…
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for stuffy noses: experimental drug targets nasal polyps
Disease control Not yet recruitingThis is a multi-center, randomized, double blind, placebo-controlled Phase III study to evaluate the efficacy and safety of CM326, and to observe the Pharmacokinetics, Pharmacodynamics and I immumogenicity\[c2.1\] of CM326 in patients with chronic rhinosinusitis with nasal polyps…
Phase 3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis is a single-arm, open-label, dose-escalation clinical trial designed to evaluate the safety, tolerability, expansion, and persistence of functionally enhanced ALPP-targeted engineered T Cells (Herein referred to as Enhanced ALPP CAR-T) in patients with ALPP-positive recurren…
Early phase 1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Ancient herb may tame inflammation after heart attack
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Tanhuo decoction works to treat acute coronary syndrome combined with cerebral atherosclerosis in the elderly. It will also learn about the safety of Tanhuo decoction. The main questions it aims to answer are: Can Tanhuo decoction r…
Sponsor: Jinggang Xia, MD • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Cord blood infusion aims to rescue cancer Patients' platelet counts
Disease control Recruiting nowThis study is a prospective, single-center, open-label, single-arm clinical trial to assess the safety and efficacy of umbilical cord blood in cancer treatment-induced thrombocytopenia (CTIT) patients. It plans to recruit subjects aged 12 to 65 years old with CTIT. The study invo…
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could an antioxidant pill speed recovery from COPD attacks?
Disease control Not yet recruitingChronic Obstructive Pulmonary Disease (COPD) is a progressive inflammatory lung disease characterized by persistent airflow limitation and enhanced oxidative stress. Acute exacerbations of COPD (AECOPD) significantly increase morbidity, accelerate lung function decline, and worse…
Phase 3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Donor t cells aim to block virus after transplant
Prevention Not yet recruitingThis study is a single-arm, open-label, dose-escalation and expansion, prospective clinical trial. Subjects will be recipients of allogeneic hematopoietic stem cell transplantation, with a planned enrollment of 9 to 18 subjects, to evaluate the safety and efficacy of JYEST cell i…
Early phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Walking workouts may boost brain power in Parkinson's patients
Symptom relief Recruiting nowThis randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of l…
Sponsor: Raphael Mendes Ritti Dias • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail aims to tackle tough lung cancers
Disease control Not yet recruitingThis is an open-label, multi-cohort, multicenter Phase Ib/II clinical study designed to evaluate the safety, tolerability, and efficacy of SYS6090 injection in combination with chemotherapy or chemotherapy and bevacizumab or SYS6010 (an EGFR ADC) in participants with advanced lun…
Phase 1/2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Ear zap during heart surgery may ward off Post-Op delirium
Symptom relief Not yet recruitingA multicenter, randomized, double-blind, sham-controlled trial to investigate the effects of intraoperative transcutaneous auricular vagus nerve stimulation (taVNS) on the incidence of postoperative delirium and negative emotional states (anxiety, depression) in patients undergoi…
Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can a simple pill stop Post-Surgery sickness? new trial aims to find out
Prevention CompletedPostoperative nausea and vomiting (PONV) are a frequent and debilitating complications after surgery, affecting up to 80% of patients at high risk in the absence of prophylaxis. Despite the rigorous application of the recommendations from the American Society of Anesthesiologist…
Phase 3 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study is an open-label, multi-center Phase IB/II clinical trial of SHR-9839(sc) combined with anti-tumor therapy in patients with advanced solid tumors, aimed at evaluating the safety, tolerability, and efficacy of SHR-9839(sc) in combination with anti-tumor therapy in patie…
Phase 1/2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC